Search Images Maps Play YouTube News Gmail Drive More »
Settings | Sign in

Hepatocellular carcinoma

Transarterial radioembolization for hepatocellular carcinoma: a review

Dove Medical Press - ‎Jul 25, 2016‎
1Department of Gastroenterology, Cisanello Hospital, Pisa, 2Endocrinology and Metabolic Diseases, Policlinico A. Gemelli, Università Cattolica del Sacro Cuore, Rome, 3Department of Engineering and Architecture, University of Trieste, Trieste ...

Sorafenib treatment alters immunosuppressive phenotypes in hepatocellular carcinoma

EurekAlert (press release) - ‎Jul 21, 2016‎
Hepatocellular carcinoma (HCC) is the most common form of liver cancer and results from long-term damage and fibrosis, such as is caused by chronic alcohol abuse and viral-induced hepatitis.

Coffee consumption and risk of hepatocellular carcinoma: a meta-analysis of eleven epidemiological studies

Dove Medical Press - ‎Jul 19, 2016‎
Abstract: Growing evidence has shown that coffee consumption is inversely related with the risk of hepatocellular carcinoma. It is suggested that caffeine maintains strong antioxidative activity. With this property, coffee intake may lead to the ...

Recent Study: Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016

Digital Journal - ‎Jul 27, 2016‎
Boston, MA -- (SBWIRE) -- 07/27/2016 -- GlobalData's clinical trial report, "Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016" provides an overview of Hepatocellular Carcinoma clinical trials scenario. This report provides top line data ...

Postoperative hepatitis B virus reactivation in hepatitis B virus-related hepatocellular carcinoma patients with ...

Dove Medical Press - ‎Jul 25, 2016‎
Background: Patients with hepatocellular carcinoma have the risk of postoperative hepatitis B virus (HBV) reactivation (PHR).

Second-Line Regorafenib Improves Overall Survival in Refractory Liver Cancer

Oncology Nurse Advisor - ‎Jul 22, 2016‎
The multikinase inhibitor regorafenib significantly improved overall survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase 3 RESORCE trial presented at the ESMO 18th World Congress of ...

Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis

Dove Medical Press - ‎Jul 21, 2016‎
Background: Cyclin D1 (CCND1) G870A polymorphism may be associated with hepatocellular carcinoma (HCC) risk, but the results of previous studies were inconsistent.

Profil Institute and HighTide Biopharmaceutical Announce a Strategic Partnership Focused on the Development of New ...

Yahoo Finance - ‎9 hours ago‎
SAN DIEGO and SHENZHEN, China, July 28, 2016 /PRNewswire/ -- Profil Institute for Clinical Research, Inc., a science-driven clinical research organization (CRO) focused exclusively on metabolic diseases, announced today a strategic master services ...
See realtime coverage

Hepatitis research and therapy around the globe – Q+A with editors and reviewers

BMC Blogs Network (blog) - ‎7 hours ago‎
Firstly, the successful implementation of a nationwide vaccination program has reduced the HBV carrier rate from >15% to <1%, together with a significant reduction of the incidence of hepatocellular carcinoma in children. A recent advance to further ...

Onxeo Reports First-Half 2016 Business Update and Consolidated Financials

Business Wire (press release) - ‎2 hours ago‎
These data showed a preferential affinity for the liver and an increased exposure in plasma compared to free doxorubicin, together supporting the use of Livatag® in the treatment of patients suffering from advanced hepatocellular carcinoma (HCC).

Researchers Look to Improve Late-Stage Liver Cancer Therapy

University of Rochester Newsroom (blog) - ‎14 hours ago‎
Liver cancer (hepatocellular carcinoma) is relatively rare but the incidence has been rising in the U.S. and elsewhere. Five-year survival rates are low at 15 percent to 30 percent for localized disease and even lower for advanced liver cancer.

Vaccination camp from today

The Hindu - ‎18 hours ago‎
He called upon the people to use the opportunity to administer the vaccine at subsidised rates. Senior gastroenterologist Shivanand Patil said that the early detection of symptoms could prevent the development of Hepatocellular carcinoma (cancer) and ...

Perspectives Toward the Elimination of Hepatitis B

PLoS Blogs (blog) - ‎9 hours ago‎
HBV and HCV infections are also responsible for 80% of hepatocellular carcinoma (HCC) and result in more than a million deaths each year around the world.

Inhibition of microRNA-126 promotes the expression of Spred1 to inhibit angiogenesis in hepatocellular carcinoma ...

Dove Medical Press - ‎Jul 19, 2016‎
Abstract: MicroRNA-126 (miR-126) has been found to promote angiogenesis, but the underlying mechanisms are still unclear. So, we conducted this study to explore the effect of miR-126 expression on angiogenesis in hepatocellular carcinoma (HCC) after ...

Statin use associated with dose-dependent reduction in cirrhosis and HCC in patients with HCV

Healio - ‎22 hours ago‎
In patients with hepatitis C, both atorvastatin and fluvastatin use were associated with a dose-dependent reduction in both cirrhosis and hepatocellular carcinoma, according to recent findings published in Hepatology.

Galmed Pharmaceuticals and SAMIL Pharm Sign a License Agreement for the Commercialization of Aramchol™ in Korea

PR Newswire (press release) - ‎6 hours ago‎
"Furthermore, in the NASH space, we also believe Aramchol™ is uniquely positioned, as it targets the underlying cause of the disease, addresses both the hepatic and metabolic-related issues, and has demonstrated a clean safety profile in its clinical ...

ASLAN Pharmaceuticals Enters Service Agreement with Selexis SA for Development of a Proprietary Cell Line for ...

Yahoo Finance - ‎Jul 27, 2016‎
... a pan-HER inhibitor with positive phase 2 data in gastric cancer, being developed in cholangiocarcinoma, breast cancer, colorectal carcinoma and gastric cancer and hepatocellular carcinoma; ASLAN002 a potent immune checkpoint inhibitor which ...

10-year-old with cancer dreams of meeting Astros players

KPRC Houston - ‎Jul 25, 2016‎
According to his stepfather, Jeremiah Price, Joseph was diagnosed Friday with hepatocellular carcinoma (HCC). As of right now, they don't know of a cure, but the family is transferring him from Texas Children's Hospital to MD Anderson for more information.

Individualized Approaches Recommended to Treat Elderly Patients with Localized HNSCC, Says Porceddu

Targeted Oncology - ‎Jul 27, 2016‎
He had a significant past history of heavy alcohol intake and prior treatment for cirrhosis of the liver and hepatocellular carcinoma. The patient was not experiencing dysphagia, weight loss, voice change, or problems with organ function. His ECOG ...

Dr. Abou-Alfa on Significance of RESORCE Trial for HCC

OncLive - ‎Jul 26, 2016‎
Ghassan K. Abou-Alfa, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the significance of the RESORCE trial, which explored regorafenib (Stivarga) versus best supportive care for patients with unresectable hepatocellular ...